Induction of inflammatory mediators in human airway epithelial cells by lipid ozonation products

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 6, 1999, Pages 1934-1942

  Kafoury, Ramzi M ^a,b   Pryor, William A ^a,b   Squadrito, Giuseppe L ^a,b   Salgo, Maria Giulia ^a,b   Zou, Xiaoyan ^a,b   Friedman, Mitchell ^a,b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; LIPID; OZONE; PHOSPHORYLCHOLINE; PROSTAGLANDIN E2; THROMBOCYTE ACTIVATING FACTOR;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; MEDIATOR RELEASE; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RESPIRATORY EPITHELIUM;

EID: 0033430374     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.6.9902025     Document Type: Article

References (64)

1. U.S. Environmental Protection Agency. 1986. Air Quality Criteria for Ozone and Other Photochemical Oxidants, National Technical Information Service, Springfield, VA. Report No. EPA/600/8-84/020df.
2. Lippmann, M. 1989. Health effects of ozone: a critical review. J. Air Poll. Control Assoc. 39:672-695.
3. Koren, H. S., R. B. Devlin, D. E. Graham, R. Mann, M. P. McGee, D. H. Horstman, W. J. Kozumbo, S. Becker, D. E. House, W. F. McDonnell, and P. A. Bromberg. 1989. Ozone-induced inflammation in the lower airways of human subjects. Am. Rev. Respir. Dis. 139:407-415.
4. Devlin, R. B., W. F. McDonnell, R. Mann, S. Becker, D. E. Hourse, D. Schreinemacher, and H. S. Koren. 1991. Exposure of humans to ambient levels of ozone for 6,6 hours causes cellular and biochemical changes in the lung. Am. J. Respir. Cell Mol. Biol. 4:72-81.
5. Devlin, R. B., W. F. McDonnell, S. Becker, M. C. Madden, M. P. McGee, R. Perez, G. Hatch, D. E. Hourse, and H. S. Koren. 1996. Time-dependent changes of inflammatory mediators in the lungs of humans exposed to 0.4 ppm ozone for 2 hr: a comparison of mediators found in bronchoalveolar lavage fluid 1 and 18 hr after exposure. Toxicol. Appl. Pharmacol. 138:176-185.
6. Pino, M. V., J. R, Levin, M. Y. Stovall, and D. M. Hyde. 1992. Pulmonary inflammation and epithelial injury in response to acute ozone exposure in the rat. Toxicol. Appl. Pharmacol. 112:64-72.
7. Basha, M. A., K. B. Gross, C. J. Gwizdala, A. H. Haidar, and J. Popovich, Jr. 1994, Bronchoalveolar lavage neutrophilia in asthmatics and healthy volunteers after controlled exposure to ozone and filtered purified air. Chest 106;1757-1765.
8. 1 and FVC do not correlate with measures of inflammation. Am. J. Respir. Crit. Care Med. 153:904-909.
9. 3 induced change in bronchial reactivity to methacholine and airway inflammation in humans. J. Appl. Physiol. 60:1321-1326.
10. Health Effects Institute. 1997. Effects of Ozone on Normal and Potentially Sensitive Human Subjects. Part I: Airway Inflammation and Responsiveness to Ozone in Normal and Asthmatic Subjects. Research Report No. 78. Cambridge, MA.
11. Koren, H. S., R. B. Devlin, S. Becker, R. Perez, and W. F. McDonnell. 1991. Time-dependent changes of markers associated with inflammation in the lungs of humans exposed to ambient levels of ozone. Toxicol. Pathol. 19:406-411.
12. Leikauf, G. D., K. E. Driscoll, and H. E. Wey. 1988. Ozone-induced augmentation of eicosanoid metabolism in epithelial cells from bovine trachea. Am. Rev. Respir. Dis. 137:435-442.
13. Samet, J. M., T. L. Noah, R. B. Devlin, J. R. Yankaskas, K. P. McKinnon, L. A. Dailey, and M. Friedman. 1992. Effect of ozone on platelet-activating factor production in phorbol-differentiated HL60 cells, a human bronchial epithelial cell line (BEAS S6), and primary human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 7:514-522.
14. McKinnon, K. P., M. C. Madden, T. L. Noah, and R. B. Devlin. 1993. In vitro ozone exposure increases release of arachidonic acid products from a human bronchial epithelial cell line. Toxicol. Appl. Pharmacol. 118:215-223.
15. Samet, J. M., and M. Friedman. 1992. Effect of ozone on platelet activating factor metabolism in phorbol-differentiated HL60 cells. Toxicol. Appl. Pharmacol. 116:19-25.
16. Wright, D. T., K. B. Adler, N. J. Akley, L. A. Dailey, and M. Friedman. 1994, Ozone stimulates release of platelet activating factor and activates phospholipases in guinea pig tracheal epithelial cells in primary culture. Toxicol. Appl. Pharmacol. 127:27-36.
17. Madden, M. C., L. A. Daily, J. M. Samet, and M. Friedman. 1998, Inhibition of arachidonic acid esterification in human airway epithelial cells exposed to ozone in vitro. Inhal. Toxicol. 10:795-811.
18. Devlin, R. B., K. P. McKinnon, T. Noah, S. Becker, and H. S. Koren. 1994. Ozone-induced release of cytokines and fibronectin production by alveolar macrophages and airway epithelial cells. Am. J. Physiol. 266:L612-L619.
19. Jaspers, I., E. Flescher, and L. C. Chen. 1997. Ozone-induced IL-8 expression and transcription factor binding in respiratory epithelial cell. Am. J. Physiol. 272:L504-L511.
20. Pryor, W. A., G. L. Squadrito, and M. Friedman. 1995. The cascade mechanism to explain ozone toxicity: the role of lipid ozonation products. Free Rad. Biol. Med. 19:935-941.
21. Pryor, W. A., and D. F. Church. 1991. Aldehydes, hydrogen peroxide, and organic radicals as mediators of ozone toxicity. Free Rad. Biol. Med. 11:41-46.
22. Holtzman, M. J., D. Grungerger, and J. A. Hunter, 1986. Phospholipid fatty acid composition of pulmonary airway epithelial cells: potential substrates for oxygenation. Biochim. Biophys. Acta 877:459-464.
23. Santrock, J., R. A. Gorski, and J. F. O'Gara. 1992. Products and mechanism of the reaction of ozone with phospholipids in unilamellar phospholipid vesicles. Chem. Res. Toxicol. 5:134-141.
24. Windrem, D. A., and W. Z. Plachy. 1980. The diffusion-solubility of oxygen in lipid bilayers. Biochim. Biophys. Acta 600:655-665.
25. Pryor, W. A. 1992. How far does ozone penetrate into the pulmonary air/tissue boundary before it reacts? Free Rad. Biol. Med. 12:83-88.
26. Criegec, R. 1975. Mechanism of ozonolysis. Angew. Chem. Inl. Ed. 14:745-752.
27. Lai, C. C., B. J. Finlayson-Pitts, and W. V. Willis. 1990. Formation of secondary ozonides from the reaction of an unsaturated phosphatidylcholine with ozone. Chem. Res. Toxicol. 3:517-523.
28. Leikauf, G. D., Q. Zhao, S. Zhou, and J. Santrock. 1993. Ozonolysis products of membrane fatty acids activate eicosanoid metabolism in human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 9:594-602.
29. Pryor, W. A. 1994. Mechanisms of radical formation from reactions of ozone with target molecules in the lung. Fret Rad. Biol. Med. 17:451-465.
30. Squadrito, G. L., R. M. Uppu, R. Cucto, and W. A. Pryor. 1992. Production of the Criegee ozonide during the ozonation of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine liposomes. Lipids 27:955-958.
31. Pryor, W. A., E. Bermudez, R. Cueto, and G. L. Squadrito. 1996. Detection of aldehydes in bronchoalvcolar lavage of rats exposed to ozone. Fundam. Appl. Pharmacol. 34:148-156.
32. 3-induced formation of bioactive lipids: estimated surface concentrations and lining layer effects. Am. J. Physiol. 274:L1006-L1016.
33. Kirichenko, A., L. Li, M. T. Morandi, and A. Holian. 1996. 4-Hydroxy-2-nonenal-protein adducts and apoptosis in murine lung cells after acute ozone exposure. Toxicol. Appl. Pharmacol. 141:416-424.
34. Hamilton, R. F., M. E. Hazbun, C. A. Jumper, W. L. Eschenbacher, and A. Holian. 1996. 4-Hydroxynonenal mimics ozone-induced modulation of macrophages ex vivo. Am. J. Respir. Cell Mol. Biol. 15:275-282.
35. 2, C, and D. Toxicol. Appl. Pharmacol. 150:338-349.
36. 2 in 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine liposomes containing lipid ozonation products. Chem. Res. Toxicol. 7:458-462.
37. Reddel, R. R., Y. Ke, B. I, Gerwin, M. G. McMenamin, J. F. Lechner, R. T. Su, D. E. Brash, J. B. Park, J. S. Rhim, and C. C. Harris, 1988. Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res. 48:1904-1909
38. Ke, Y., R. R. Reddel, B. I. Gerwin, M. Miyashita, M. McMenamin, J. F. Lechner, and C. C. Harris. 1988. Human bronchial epithelial cells with integrated SV40 virus T antigen genes retain the ability to undergo squamous differentiation. Differentiation 38:60-66.
39. Asano, K., C. M. Lilly, and J. M. Drazen. 1996. Prostaglandin G/H synthase-2 is the constitutive and dominant isoform in cultured human lung epithelial cells. Am. J. Physiol. 271:L126-L131.
40. Churchill, L., F. H. Chilton, J. H. Resau, R. Bascom, W. C. Hubbard, and D. Proud. 1989. Cyclooxygenase metabolism of endogenous arachidonic acid by cultured human tracheal epithelial cells. Am. Rev. Respir. Dis. 140:449-459.
41. Alpert, S. E., R. W. Walenga, C. M. Kramer, C. L. Silski, and P. B. Davis. 1992. Tracheal epithelial cell fatty acid composition modulates prostaglandin E2 and cAMP production. Am. J. Physiol. 262:L192-L197.
42. Daniel, W. W. 1991. Biostatistics: A Foundation for Analysis in Health Sciences, 5th ed. John Wiley, New York. 274-366.
43. Devlin, R. B., L. J. Folinsbee, K Biscardi, S. Becker, M. C. Madden, M. Robins, and H. Koren. 1997. Inflammation and cell damage induced by repeated exposure of humans to ozone. Inhal. Toxicol. 9:211-235.
44. 2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells. Life Sci. 60:67-78.
45. Chung, K. F. 1992. Platelet-activating factor in inflammation and pulmonary disorders. Clin. Sci. 83:127-138.
46. Kaneko, T., H. Ikeda, L. Fu, H. Nishiyama, and T. Okubo. 1995. Platelet-activating factor mediates the ozone-induced increase in airway microvascular leakage in guinea pigs. Eur. J. Pharmacol. 292:251-255.
47. Shukla, S. D. 1992. Platelet-activating factor receptor and signal transduction mechanisms. FASEB J. 6:2296-2301.
48. 2 blocks eicosanoid and platelet activating factor biosynthesis and has topical anti-inflammatory activity. J. Pharmacol. Exp. Ther. 271:852-859.
49. Shukla, S. D. 1991. Inositol phospholipid turnover in PAF transmembranc signalling. Lipids 26:1028-1033.
50. 4 by human neutrophils. J. Biol. Chem. 262:15370-15376.
51. Fuse, I., T. Iwanaga, and H.-H. Tai. 1989. Phorbol ester, 1,2-diacylglycerol, and collagen induce inhibition of arachidonic acid incorporation into phospholipids in human platelets. J. Biol. Chem. 264:3890-3895.
52. Smith, W. L., and D. L. DeWitt. 1995. Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential suscep-tibility to nonsteroidal anti-inflammatory drugs. Sem. Nephrol. 15:179-194.
53. Henderson, W. R., Jr. 1994. The role of leukotrienes in inflammation. Ann. Intern. Med. 12:684-697.
54. Roshak, A., G. Sathe, and L. A. Marshall. 1994. Suppression of monocyte 85-kDa phospholipase A2 by antisense and effects on endotoxininduced prostaglandin biosynthesis. J. Biol. Chem. 269:25999-26005.
55. 2. Biochim. Biophys. Acta 1300:197-202.
56. 2 production in mouse peritoneal macrophages. Eur. J. Pharmacol. 253:155-161.
57. DeForge, L. E., A. M. Preston, E. Takeuchi, J. Kenney, L. A. Boxer, and D. G. Remick. 1993. Regulation of interleukin 8 gene expression by oxidant stress. J. Biol. Chem. 268:25568-25576.
58. Chabot-Fletcher, M., J. Breton, J. Lee, P. Young, and D. E. Griswold. 1994. Interleukin-8 production is regulated by protein kinase C (PKC) in human keratinocytes. J. Invest. Dermatol. 103:509-515.
59. Gross, V.,T. Andus, R. Daig, E. Aschenbrenner, J. Scholmerich, and W. Falk. 1995, Regulation of interleukin-8 production in a human colon epithelial cell line (HT-29). Gastroenterology 108:653-661.
60. Jaspers, I., L. C. Chen, and E. Flescher. 1998. Induction of interleukin-8 by ozone is mediated by tyrosine kinase and protein kinase A, but not by protein kinase C. J. Cell. Physiol. 177:313-323.
61. Gordge, P. C., and W. J. Ryves. 1994. Inhibitors of protein kinase C. Cellular Signaling 6:871-882.
62. Bruns, R. F., F. D. Miller, R. L. Merriman, J. J. Howbert, W. F. Heath, E. Kobayashi, I. Takahashi, T. Tamaoki, and H. Nakano. 1991. Inhibition of protein kinase C by Calphostin C is light-dependent. Binchem. Biophys. Res. Commun. 176:288-293.
63. Kobayashi, E., H. Nakano, M. Morimoto, and T. Tamaoki. 1989. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 159:548-553.
64. Kafoury, R. M., E. Gozal, G. L. Squadrito, X. Zou, W. A. Pryor, and M. Friedman. 1999. Lipid ozonation products activate nuclear factor-κB (NFκB) in human bronchial epithelial cells (BEAS-2B) (abstract). Am. J. Respir. Crit. Care Med. 159:A463.